Molecular cytogenetic analysis of 11 new breast cancer cell lines - Wikidata - wikimedia - TriplyDB

Molecular cytogenetic analysis of 11 new breast cancer cell lines

Molecular cytogenetic analysis of 11 new breast cancer cell lines

http://www.wikidata.org/entity/Q36619975

about

SUM102PT SUM1315MO2 SUM149PT SUM159PT SUM185PE SUM190PT SUM206CWN SUM225CWN SUM229PE SUM44PE SUM52PE

P1343

Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers EGFR/Met association regulates EGFR TKI resistance in breast cancer Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE Breast cancer cell lines: friend or foe?Update on inflammatory breast cancer Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers Developmental therapeutics for inflammatory breast cancer: Biology and translational directions Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.In vivo lymphatic imaging of a human inflammatory breast cancer model.Dynamin recruitment and membrane scission at the neck of a clathrin-coated pit.Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells.Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways.Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.Molecular characterisation of cell line models for triple-negative breast cancers.E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer N-glycosylation regulates ADAM8 processing and activation Inflammatory breast cancer (IBC): clues for targeted therapies Transforming properties of 8p11-12 amplified genes in human breast cancer.Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin Genetic alterations of histone lysine methyltransferases and their significance in breast cancer The role of estrogen in the initiation of breast cancer

P2860

Q54970826-E3A616DF-1A7A-4B21-85EF-862415BA5ABA Q54970827-290E8695-0B66-4A39-BB1C-14112C5DD7DF Q54970832-FD20B424-395D-4995-9672-ADC23C0BC479 Q54970841-F62A2CED-A5B7-4B1B-8DB5-B004013EA738 Q54970844-9379CBAB-405F-48F8-AB23-BA363D9F2E4D Q54970845-BEFBB7B4-CF3C-40B6-8535-BBF750C16FB6 Q54970846-F0A1CB4C-0E0F-45B1-B5F5-C81B16EB6A05 Q54970848-99E83A6C-4C21-4AFA-9709-8B25F52B4F94 Q54970849-4F960C5F-E154-4E22-890A-B310EBADDC91 Q54970850-1D8EBAEA-106C-4DD1-A032-857834FEBD12 Q54970851-3207FA39-BA36-493B-865E-214FDCB87006

P1343

Q21145245-F6C887B8-3560-4E34-A3DA-AEDB109C7E86 Q22000757-915A052E-0C13-42C6-8272-8FA6D3C2AFB7 Q24309483-4BDD5A17-79FC-48FC-8B82-2E077DF09CC0 Q24338635-7F6EDD8F-A2CC-4F1B-82BE-6096F2A157E7 Q24651943-2FA190DA-78C9-4FA4-97E2-9AE9B698E0D9 Q24791357-F9CEC296-01B5-4029-AB24-57724EB40E57 Q24795678-728B6578-0B58-48DB-9E79-9C342D8524E1 Q24797853-708D9705-B35E-49EA-8C06-1497EC3F8E80 Q24801016-CFEAC34A-1B8E-4794-80AA-4FEDD2364037 Q26864448-E08F8B16-31BD-4272-A5E2-25C70C5C4EC5 Q26998955-F7CB324C-B370-41E4-A0AB-4FE05093A3B6 Q28075322-89399649-15A8-4A3A-BD16-986B7AAFAE58 Q28259744-D9723F5F-80C8-4759-BE00-3A27441D6F10 Q28543036-58673B58-C86B-49A4-81CA-80CF4ADA82AB Q30500481-829F8905-DBD2-4EA4-BB1B-65CE6CC79FE3 Q30596741-44455AFE-FA80-4CB0-AC3D-4CA7DA95C2F8 Q30597678-2C8F226C-9DF0-4152-B96A-493CB8A14FB3 Q30744558-11D239D8-46F6-4181-BE26-D7A823956658 Q30999913-13DC0083-1BC6-47F0-A5A2-7AE055353C8B Q31138996-FC014052-6919-466D-A046-EBE3590C1E9D Q33675150-814C8214-EE04-4EA5-8DF0-DBB213D2146D Q33855516-7BA72C25-EEF1-451A-9752-44D8B4EA6C80 Q33870504-9773B8DD-4EE7-4898-A212-31655D4543F0 Q33942512-714CAB0C-8B03-4FBC-978E-9C554BC0F89E Q34079994-F9527DD3-C7A8-4D17-B3CE-02833D6CA57A Q34214918-1CCF659F-AF99-43CE-B7CD-DB5EC68B1C55 Q34297659-F5C20046-3600-407C-B6D1-163510FD6AB0 Q34360155-38CB9E99-9BBB-4654-8376-80128E80A70D Q34439389-7363B8F1-143D-4994-87D7-8A862ED21CF8 Q34476551-F5AF09BE-CFE6-486F-8AFB-42B30E977DAB Q34497064-AF748FA4-E400-4BF4-BA28-5AE09D0EAC4A Q34528297-461FBE47-803A-4D02-B64D-3143EE8DCC8D Q34580432-694172EE-04F4-40C4-ACB3-2F018A315EB2 Q34754098-E02130BB-EB24-457F-99F7-7EDE2F928539 Q34950377-2C682F0A-3047-4C59-9C24-33CE1BE0F751 Q34994744-BE72DED2-50BB-4B89-B34B-6F3661C10A10 Q35007438-9DA6F0CA-E12E-4B96-B9DA-F3959668DEF4 Q35041632-6A702A4D-C91C-43DE-A02B-1AD55260733D Q35273743-7151B35D-6CC7-4D8C-8BF5-739837F79162 Q35698844-1E47D7A3-EB5F-455D-9520-BBE2FEB965F8

P2860

Molecular cytogenetic analysis of 11 new breast cancer cell lines

http://www.wikidata.org/entity/Q36619975

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@ast

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@en

type

label

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@ast

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@en

prefLabel

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@ast

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@en

P1433

Q36619975-63773B5A-4A68-40CE-84C5-632A2E2C363A

P1476

Q36619975-DB694F75-B0F7-484E-8C4C-7CDD31151633

P2093

Q36619975-14BFE5F3-5253-4B94-B998-81195B8E7B30

Q36619975-21E44254-5C8F-4AFF-8B04-4963DB247255

Q36619975-8591B0BD-7095-4B89-B2C7-E8ACD39EE95C

Q36619975-8D0350F0-49CF-4EEC-9DD7-29C0D9008A07

Q36619975-D8EE3460-CEE5-4643-AEE9-9BC1AC125B9C

Q36619975-D9113E60-CFEB-4E56-9654-59817F27DB12

P2860

Q36619975-14B7C5FC-C971-4926-85D4-20D297EF241F

Q36619975-31B4EABE-4FAD-41E8-818A-B0FC14653D48

Q36619975-33C8007E-0EF8-4955-8917-4C60B2786EE9

Q36619975-49D00D4A-D16C-4B76-BE56-3D7E4FCDB9F3

Q36619975-4DBE5C68-1609-408C-A185-1048F98B8641

Q36619975-6A5B0830-158D-40FF-90D2-FB8DE3EEC30F

Q36619975-75AF5AB1-2B87-4E07-A1F2-CB17FED01D2C

Q36619975-7834D975-0950-4D00-844F-0557F4E40E8C

Q36619975-93A74EB9-7F96-4BD2-B8EB-3C2ABE39CA38

Q36619975-9914784C-3F2D-431A-9B6A-494AEA39261F

P2888

Q36619975-2DB97CD5-8776-449F-B71E-41B7F6EC5D9F

P304

Q36619975-95ECB497-2ECB-4B10-AB3E-901F09629DA2

P31

Q36619975-3F685C84-71FC-4689-9D29-BA549CBA88D5

P356

Q36619975-F9FA7DB2-F079-499C-BBE4-1745CB406417

P407

Q36619975-5FDE861E-FCE4-4357-9AA8-96A406B74F4E

P433

Q36619975-DFBDAD2A-1514-40CE-ACAC-1D2BF1E9C4D8

P4510

Q36619975-010D1F30-37CA-4AEC-8EDD-695CB0ACBA8A

Q36619975-1BFADD35-0123-45D2-9A15-9F6857E96DAC

Q36619975-24B967A8-B4D8-439F-BD76-C2B202E1AA19

Q36619975-5708DD6F-240F-4C1D-BE08-EDC9C48695CE

Q36619975-79033108-7E5D-4AF0-9254-6B0FB38053E2

Q36619975-79B91716-2D3A-474C-AA81-969E01072EC3

Q36619975-83FFD95A-9160-421B-B70B-B8DA557278B4

Q36619975-A8B1E8B4-C3D3-4B76-B609-C7691A9E0F4E

Q36619975-B26D9732-18B4-413D-8AA6-FD5E4037FABD

Q36619975-EB88D0BC-FA10-48F1-AA37-857C5D11D9DC

P478

Q36619975-36F4115A-62A1-4B55-9572-DE6EC5D290B1

P50

Q36619975-DE0E6990-328C-45AC-91AC-F6D65BA4F6D8

P577

Q36619975-E30B6949-E79D-44EF-A1F1-F721EA042FDB

P5875

Q36619975-29431986-C6CF-4C00-A4BF-AF04B556566E

P698

Q36619975-2C353BCE-88E2-44A3-8EA1-71E14E27BCFB

P921

Q36619975-1DF3A24D-33F9-4317-9B6F-57AE77FDA6BD

P932

Q36619975-7AACCF7C-9FFC-4216-930D-BCCFE6421B26

P356

P1433

British Journal of Cancer

P1476

Molecular cytogenetic analysis of 11 new breast cancer cell lines

@en

P2093

Ammerman CA

http://www.w3.org/2001/XMLSchema#string

Ethier SP

http://www.w3.org/2001/XMLSchema#string

Forozan F

http://www.w3.org/2001/XMLSchema#string

Kallioniemi A

http://www.w3.org/2001/XMLSchema#string

Parsa NZ

http://www.w3.org/2001/XMLSchema#string

Veldman R

http://www.w3.org/2001/XMLSchema#string

P2860

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Human breast cancer cell lines as models of growth regulation and disease progression.

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

High frequency of aberrant p16(INK4A) expression in human breast cancer

P2888

P304

1328-1334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6695007

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P4510

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12696205

http://www.w3.org/2001/XMLSchema#string

P698

10604729

http://www.w3.org/2001/XMLSchema#string

P921

P932

2362964

http://www.w3.org/2001/XMLSchema#string